Cognition After OSA Treatment Among Native American People (CATNAP)
CATNAP
Cognition After Obstructive Sleep Apnea (OSA) Treatment Among Native American People (CATNAP)
1 other identifier
interventional
140
1 country
1
Brief Summary
This research project will develop and implement a motivational interviewing and electronic messaging intervention to address obstructive sleep apnea (OSA), positive airway pressure (PAP) adherence, and risk of Alzheimer's disease and related dementias in American Indians. The project will work with American Indian Elders, aged 50 years and older, from three Northern Plains Reservations and surrounding communities. A total of 300 American Indian elders with a confirmed OSA diagnosis and prescribed PAP therapy will be randomized to receive usual care consisting of PAP therapy alone (control condition) or usual care plus the culturally informed CATNAP MI component (intervention condition).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Feb 2025
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 23, 2022
CompletedFirst Posted
Study publicly available on registry
January 29, 2024
CompletedStudy Start
First participant enrolled
February 6, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2027
January 9, 2026
January 1, 2026
2.9 years
February 23, 2022
January 7, 2026
Conditions
Outcome Measures
Primary Outcomes (3)
Positive Airway Pressure (PAP) minutes per night
Participant mask-on time data collected by the PAP equipment will be extracted as continuous minutes per night.
9 months
Nights of PAP use
Proportion of nights with 4+ hours of PAP use from PAP device
9 months
PAP adherence
Use of device for more than 240 minutes per night, on 21 or more days out of the past 30 days. From PAP device.
9-months
Secondary Outcomes (2)
Montreal Cognitive Assessment total score
9 months
Cognivue total score
9 months
Study Arms (2)
Intervention Group
EXPERIMENTALThe CATNAP MI intervention consists of 3 Motivational Interviewing sessions to address obstructive sleep apnea (OSA), positive airway pressure (PAP) adherence, and risk of Alzheimer's disease and related dementias (ADRD) in American Indians and electronic messaging to support PAP adherence, and usual care. Data will be collected at baseline, 3-months, and 9-months.
Waitlist Control Group
NO INTERVENTIONUsual care, consisting of an in-service on how to operate the PAP machine, and a mask fitting to select the most comfortable, effective mask for the individual. After 4-6 weeks of use, the participant will be contacted by Missouri Breaks Durable Medical Equipment to review objective adherence data and address any challenges or barriers to therapy such as treatment-emergent central apneas. Data will be collected at baseline, 3-months, and 9-months.
Interventions
Three motivational interviewing (MI) sessions will be facilitated by trained MI staff and will focus on improving participants' knowledge about their OSA diagnosis, understanding of sleep health, and increasing PAP use. Sessions will also provide information about health benefits associated with good sleep and will help participants create an action plan regarding their PAP use and indicators of success, when appropriate. Electronic messaging will be standardized for frequency and content but personalized to participants' preferred mode of delivery. Messages will focus on PAP adherence or non-adherence.
Eligibility Criteria
You may qualify if:
- Age 50 years and older
- Self report American Indian or Alaskan Native
- diagnosed with obstructive sleep apnea
- prescribed PAP therapy and have a device
- \*Ability to understand written and spoken English; and
- \*Ability and willingness to follow all study protocols.
You may not qualify if:
- Living in a household with someone who is enrolled in the study
- Already using PAP device at Medicaid recommended standards
- Cognitive decline, unable to consent on their own
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Washington State Universitylead
- Missouri Breaks Industries Research, Inc.collaborator
- University of Washingtoncollaborator
- University of Minnesotacollaborator
Study Sites (1)
Missouri Breaks Industries Research Inc
Eagle Butte, South Dakota, 57625, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
February 23, 2022
First Posted
January 29, 2024
Study Start
February 6, 2025
Primary Completion (Estimated)
December 31, 2027
Study Completion (Estimated)
December 31, 2027
Last Updated
January 9, 2026
Record last verified: 2026-01
Data Sharing
- IPD Sharing
- Will not share